This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's How Colgate (CL) is Poised Ahead of Q1 Earnings
by Zacks Equity Research
Colgate's (CL) first-quarter 2023 sales are likely to have gained from innovation, brand strength, focus on premiumization and expansion efforts.
Don't Overlook These Top-Rated Stocks Before Earnings
by Shaun Pruitt
Two stocks that are worthy of investors' consideration going into their first-quarter earnings reports on Friday, April 28 are Colgate-Palmolive (CL) and WisdomTree (WT).
Here's How FEMSA (FMX) is Placed Just Before Q1 Earnings
by Zacks Equity Research
FEMSA (FMX) Q1 results are expected to reflect gains from strong demand trends, digital growth, strong segmental results and expansion initiatives.
Here's How Newell (NWL) is Poised Ahead of Q1 Earnings
by Zacks Equity Research
Despite tough environment, reduced inventory and inflationary pressures, productivity and efficiency initiatives and digital growth are likely to have aided Newell's (NWL) Q1 earnings.
What's in Store for Service Corporation (SCI) in Q1 Earnings?
by Zacks Equity Research
Service Corporation's (SCI) first-quarter 2023 performance is likely to have been adversely impacted by rising inflationary pressure. Strength in the preened cemetery sales has been an upside.
Lumen (LUMN) to Report Q1 Earnings: Here's What to Expect
by Zacks Equity Research
Lumen's (LUMN) Q1 performance is likely to have been affected by supply-chain woes, macroeconomic weakness and dissynergies from the sale of ILEC and Latin America businesses
Factors Likely to Influence Boston Beer's (SAM) Q1 Earnings
by Zacks Equity Research
Boston Beer's (SAM) Q1 results are expected to reflect significant impacts of a slowdown in hard seltzer trends, increased supply-chain costs and higher operating expenses.
Clorox (CLX) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
VeriSign (VRSN) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
VeriSign (VRSN) first-quarter performance is expected to have benefited from growing Internet consumption. However, ongoing weakness in global macroeconomic conditions might have been a concern.
How Keurig Dr Pepper's (KDP) Looks Just Ahead of Q1 Earnings
by Zacks Equity Research
Although inflation has been concerning, continued strength in Packaged Beverages and strong in-market performances are likely to have aided Keurig Dr Pepper's (KDP) Q1 performance.
Church & Dwight (CHD) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Church & Dwight's (CHD) first-quarter 2023 results are likely to reflect profit from strong consumer demand. It is likely to reflect benefits from strong pricing action incurred to counter inflation.
Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Beats on Q3 Earnings and Sales, Ups View
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results benefit from robust pricing and a favorable mix, along with strength across its segments.
Colgate-Palmolive (CL) Just Reclaimed the 200-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
Colgate-Palmolive (CL) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Archer Daniels (ADM) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Archer Daniels' (ADM) first-quarter 2023 results are likely to reflect headwinds from higher costs and inflationary pressure. However, gains from solid demand are likely to aid the results.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Here's Why Investors Should Hold Colgate (CL) Stock for Now
by Zacks Equity Research
Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.
Zacks Industry Outlook Highlights The Procter & Gamble, Colgate-Palmolive, Henkel AG, Church & Dwight and The Clorox
by Zacks Equity Research
The Procter & Gamble, Colgate-Palmolive, Henkel AG, Church & Dwight and The Clorox are part of the Zacks Industry Outlook article.
5 Soaps & Cleaning Materials Stocks to Watch as Industry Catches Pace
by Rajani Lohia
The soap and cleaning materials industry looks poised for growth on robust demand, pricing initiatives, innovation, digital transformation and brand building, while elevated costs remain headwinds. Players like PG, CL, HENKY, CHD and CLX seem well-poised.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Colgate (CL) Earnings Meet Estimates in Q4, Sales Surpass
by Zacks Equity Research
Despite challenging macroeconomic conditions, gains from revenue growth management plans and continued momentum aid Colgate's (CL) Q4 results.
PCE Inflation Declined in December
by Zacks Equity Research
PCE Inflation Declined in December
PCE Melts Gently Overall; AXP, CVX, CL Post Q4 Results
by Mark Vickery
Year over year, headline PCE came in at +5.0%, a half-point lower than November's +5.5%.